Changmao Biochemical Engineering Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chun Pan
Chief executive officer
CN¥699.0k
Total compensation
| CEO salary percentage | 79.1% |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Further Upside For Changmao Biochemical Engineering Company Limited (HKG:954) Shares Could Introduce Price Risks After 25% Bounce
Sep 23
Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist
Aug 02Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled
Nov 18We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability
Apr 28Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns
Aug 03Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital
May 04Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield
Feb 23Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?
Jan 26
A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary
Dec 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥109m |
| Mar 31 2024 | n/a | n/a | -CN¥98m |
| Dec 31 2023 | CN¥699k | CN¥553k | -CN¥86m |
| Sep 30 2023 | n/a | n/a | -CN¥21m |
| Jun 30 2023 | n/a | n/a | CN¥45m |
| Mar 31 2023 | n/a | n/a | CN¥63m |
| Dec 31 2022 | CN¥2m | CN¥545k | CN¥81m |
| Sep 30 2022 | n/a | n/a | CN¥90m |
| Jun 30 2022 | n/a | n/a | CN¥99m |
| Mar 31 2022 | n/a | n/a | CN¥79m |
| Dec 31 2021 | CN¥701k | CN¥563k | CN¥58m |
| Sep 30 2021 | n/a | n/a | CN¥30m |
| Jun 30 2021 | n/a | n/a | CN¥2m |
| Mar 31 2021 | n/a | n/a | CN¥9m |
| Dec 31 2020 | CN¥641k | CN¥538k | CN¥17m |
| Sep 30 2020 | n/a | n/a | CN¥24m |
| Jun 30 2020 | n/a | n/a | CN¥31m |
| Mar 31 2020 | n/a | n/a | CN¥45m |
| Dec 31 2019 | CN¥1m | CN¥745k | CN¥58m |
| Sep 30 2019 | n/a | n/a | CN¥69m |
| Jun 30 2019 | n/a | n/a | CN¥79m |
| Mar 31 2019 | n/a | n/a | CN¥65m |
| Dec 31 2018 | CN¥889k | CN¥545k | CN¥51m |
| Sep 30 2018 | n/a | n/a | CN¥34m |
| Jun 30 2018 | n/a | n/a | CN¥17m |
| Mar 31 2018 | n/a | n/a | CN¥10m |
| Dec 31 2017 | CN¥683k | CN¥543k | CN¥3m |
Compensation vs Market: Chun's total compensation ($USD95.80K) is below average for companies of similar size in the Hong Kong market ($USD230.70K).
Compensation vs Earnings: Chun's compensation has been consistent with company performance over the past year.
CEO
Chun Pan (54 yo)
no data
Tenure
CN¥699,000
Compensation
Mr. Chun Pan has been General Manager of Changmao Biochemical Engineering Company Limited since April 1, 2014 and also serves as its Chief Executive Officer. He joined Changmao Biochemical in August 1993....
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Compliance Officer | no data | CN¥800.00k | 2.3% HK$ 4.9m | |
| CEO, GM & Executive Director | no data | CN¥699.00k | no data | |
| Chief Officer & Employee Representative Supervisor | 11.7yrs | CN¥104.00k | no data | |
| Non-Executive Director | no data | CN¥60.00k | 0.0098% HK$ 20.8k | |
| Non-Executive Director | no data | CN¥60.00k | 13.17% HK$ 27.9m | |
| Non-Executive Director | no data | CN¥60.00k | no data | |
| Chairman of the Supervisory Board | no data | CN¥56.00k | no data | |
| Non-Executive Director | 17.5yrs | CN¥60.00k | no data | |
| Independent Non-Executive Director | 2.5yrs | CN¥80.00k | no data | |
| Supervisor | 2.5yrs | no data | no data | |
| Independent Non-Executive Director | 2.5yrs | CN¥80.00k | no data | |
| Independent Non-Executive Director | 2.4yrs | CN¥80.00k | no data |
2.5yrs
Average Tenure
64.5yo
Average Age
Experienced Board: 954's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:33 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Changmao Biochemical Engineering Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|